查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1775461

实验室设备市场：2025-2030 年预测

Lab Equipment Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

实验室设备市场预计将从 2025 年的 195.07 亿美元成长到 2030 年的 273.1 亿美元，复合年增长率为 6.96%。

加大对医药研发的投入

製药公司正在大幅加大研发投入以应对慢性疾病，这为实验室器具市场创造了巨大的商机。根据产业报告显示，2024 年全球医药品研究开发费用将达到 2,800 亿美元，重点在于开发创新药物和生技药品。政府倡议正在透过简化临床试验流程进一步加速这一趋势。例如，欧洲药品管理局于 2023 年引入了快速通道系统，将基因和细胞治疗试验的核准时间从 25 天缩短至 30 天，使公司能够优先考虑药物开发。活性化推动了对光谱仪、搅拌机和电导率计等先进实验室器具的需求，这些器具对于药物发现和测试至关重要。

慢性病盛行率上升

癌症、糖尿病和心血管疾病等慢性病负担的加重是市场成长的主要驱动力。根据美国卫生与美国服务部的数据，2024 年美国将诊断出超过 190 万例新癌症病例，导致约 61 万人死亡，癌症成为第二大死因。此外，约有 3,800 万美国人患有糖尿病，这增加了心臟病和肾衰竭的风险。这些疾病需要先进的诊断和药物开发，从而推动了对支持有效治疗方法研究的实验室仪器的需求。全球范围内慢性病的增加，尤其是老龄化人口的增加，进一步推动了对尖端检测工具的需求。

生技药品需求不断成长

生技药品，对市场成长做出了巨大贡献。根据世界卫生组织（WHO）国际临床註册平台的数据，到2024年，生技药品将占据药品研发线的很大一部分，全球整体将集中于此类治疗。生技药品针对癌症和自体免疫疾病等常见疾病，需要专门的实验室设备进行开发和测试。由于生技药品的疗效和日益增长的消费者需求，生技药品研究蓬勃发展，这推动了对先进测试工具的需求，从而进一步刺激市场扩张。

市场区隔分析

按类型

实验室仪器市场细分为具有样品特性感测功能的仪器（光谱仪、电导率仪等）及不具样品特性感测功能的仪器（搅拌机、加热炉等）。感测领域占据主导地位，因为它在精准诊断和药物开发中发挥着至关重要的作用，尤其是在生技药品和慢性病研究中。

按最终用户

市场细分为政府、生物製药、工业和其他终端用户。生物製药领域在2024年占据最大份额，这得益于高额研发投入和药物研发对专用设备的需求。政府机构和学术研究机构也是主要贡献者，并得到了公共医疗研究资金的支持。

地理洞察力

由于先进的医疗基础设施和美国领先的生物製药公司，北美占据了重要的市场占有率。 2024年，该地区将占据全球实验室用具收益的35%以上，这得益于其强大的研发生态系统。由于慢性病发病率上升以及中国和印度等国家医药投资的增加，亚太地区成长最快。例如，印度2024年的医疗保健预算已拨款150亿美元用于研发，这将刺激对实验室用具的需求。紧随其后的是欧洲，由于监管部门对创新治疗方法的支持，该地区也将迎来强劲成长。

竞争考察

艾本德（Eppendorf AG）、罗氏公司（F. Hoffmann-La Roche Ltd）、安捷伦科技公司（Agilent Technologies, Inc.）和赛默飞世尔科技公司（Thermo Fisher Scientific Inc.）等主要企业凭藉其强大的品牌声誉和创新产品占据市场主导地位。 2023年，赛默飞世尔科技推出了专为生技药品研究量身定制的先进光谱仪器，以提高药物开发的精确度。安捷伦于2024年推出自动化实验室解决方案，以提高高通量测试的效率。这些公司利用策略性收购和研发投资来维持市场领先地位。

市场挑战

先进实验室设备的高成本以及对操作复杂系统的熟练人员的需求构成了挑战，尤其是在发展中地区。此外，临床试验设备严格的监管要求可能会减缓其市场准入速度，并迫使其持续创新以满足合规标准。

本报告的主要优点

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策并在动态环境中发现新的业务来源和收益。
  • 受众范围广：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具成本效益的。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2024 年的实际数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（策略、产品、财务、主要发展等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球实验室设备市场（按类型）

  • 介绍
  • 分析设备
  • 通用实验室设备
  • 测量/监测设备
  • 专用设备
  • 支援的设备

第六章全球实验室设备市场（按最终用户）

  • 介绍
  • 学术和研究机构
  • 生物製药和製药公司
  • 医疗保健和诊断实验室
  • 政府和监管机构
  • 工业/製造业
  • 其他的

7. 全球实验室设备市场（按地区）

  • 介绍
  • 北美洲
    • 按类型
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按类型
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按类型
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按类型
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按类型
    • 按最终用户
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章：公司简介

  • Eppendorf AG
  • Beckman Coulter, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • F. Hoffmann-La Roche Ltd
  • Shimadzu Corporation
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.

第十章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613570

The Lab Equipment Market is expected to grow from USD 19.507 billion in 2025 to USD 27.310 billion in 2030, at a CAGR of 6.96%.

Increasing Investments in Pharmaceutical R&D

Pharmaceutical companies are significantly boosting R&D investments to address chronic diseases, creating substantial opportunities for the lab equipment market. In 2024, global pharmaceutical R&D spending reached USD 280 billion, with a focus on developing innovative drugs and biologics, according to industry reports. Government initiatives are further accelerating this trend by streamlining clinical trial processes. For instance, in 2023, the European Medicines Agency introduced fast-track schemes reducing approval times for gene and cell therapy trials by 25-30 days, enabling companies to prioritize drug development. This heightened R&D activity drives demand for advanced lab equipment, such as spectrometers, mixers, and conductivity meters, essential for drug discovery and testing.

Rising Prevalence of Chronic Diseases

The growing burden of chronic diseases, including cancer, diabetes, and cardiovascular conditions, is a key driver of market growth. In the United States, over 1.9 million new cancer cases were diagnosed in 2024, with approximately 610,000 deaths, making it the second leading cause of mortality, per the U.S. Department of Health and Human Services. Additionally, around 38 million Americans live with diabetes, increasing risks of heart disease and kidney failure. These conditions necessitate advanced diagnostics and drug development, boosting demand for lab equipment to support research into effective treatments. The global rise in chronic diseases, particularly in aging populations, further amplifies the need for cutting-edge laboratory tools.

Growing Demand for Biologics

The increasing popularity of biologics-drugs derived from living organisms-is significantly contributing to market growth. In 2024, biologics accounted for a substantial portion of the pharmaceutical pipeline, with 40% of clinical trials globally focused on these therapies, according to the World Health Organization's International Clinical Registry Platform. Biologics target prevalent diseases like cancer and autoimmune disorders, requiring specialized lab equipment for development and testing. This surge in biologics research, driven by their efficacy and growing consumer demand, is propelling the need for advanced laboratory tools, further fueling market expansion.

Market Segmentation Analysis

By Type

The lab equipment market is segmented into equipment with sample characteristic sensing (e.g., spectrometers, conductivity meters) and without sample characteristic sensing (e.g., mixers, furnaces). The sensing segment dominates due to its critical role in precise diagnostics and drug development, particularly for biologics and chronic disease research.

By End-User

The market is classified into government, biopharmaceutical, industrial, and other end-users. The biopharmaceutical segment held the largest share in 2024, driven by heavy R&D investments and the need for specialized equipment in drug discovery. Government and academic research institutions are also significant contributors, supported by public funding for health research.

Geographical Insights

North America holds a significant market share, driven by advanced healthcare infrastructure and the presence of major biopharmaceutical companies in the U.S. In 2024, the region accounted for over 35% of global lab equipment revenue, bolstered by robust R&D ecosystems. The Asia-Pacific region is the fastest-growing, fueled by rising chronic disease prevalence and increasing pharmaceutical investments in countries like China and India. For instance, India's 2024 healthcare budget allocated USD 15 billion for R&D, enhancing lab equipment demand. Europe follows, with strong growth driven by regulatory support for innovative therapies.

Competitive Insights

Key players, including Eppendorf AG, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Thermo Fisher Scientific Inc., dominate the market due to their strong brand reputation and innovative product offerings. In 2023, Thermo Fisher launched advanced spectrometry equipment tailored for biologics research, enhancing precision in drug development. Agilent introduced automated lab solutions in 2024, improving efficiency in high-throughput testing. These companies are leveraging strategic acquisitions and R&D investments to maintain market leadership.

Market Challenges

High costs of advanced lab equipment and the need for skilled personnel to operate complex systems pose challenges, particularly in developing regions. Additionally, stringent regulatory requirements for equipment used in clinical trials can delay market entry, requiring continuous innovation to meet compliance standards.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Lab Equipment Market Segmentation

By Type

  • Analytical Instruments
  • General Lab Equipment
  • Measuring & Monitoring Devices
  • Specialty Equipment
  • Support Equipment

By End-User

  • Academic & Research Institutes
  • Biopharmaceutical & Pharmaceutical Companies
  • Healthcare & Diagnostic Labs
  • Government & Regulatory Bodies
  • Industrial & Manufacturing
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL LAB EQUIPMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Analytical Instruments
  • 5.3. General Lab Equipment
  • 5.4. Measuring & Monitoring Devices
  • 5.5. Specialty Equipment
  • 5.6. Support Equipment

6. GLOBAL LAB EQUIPMENT MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Academic & Research Institutes
  • 6.3. Biopharmaceutical & Pharmaceutical Companies
  • 6.4. Healthcare & Diagnostic Labs
  • 6.5. Government & Regulatory Bodies
  • 6.6. Industrial & Manufacturing
  • 6.7. Others

7. GLOBAL LAB EQUIPMENT MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
      • 7.2.3.1. USA
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. By Type
    • 7.3.2. By End-User
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. By Type
    • 7.4.2. By End-User
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
      • 7.4.3.2. Germany
      • 7.4.3.3. France
      • 7.4.3.4. Spain
      • 7.4.3.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Type
    • 7.5.2. By End-User
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. UAE
      • 7.5.3.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Type
    • 7.6.2. By End-User
    • 7.6.3. By Country
      • 7.6.3.1. China
      • 7.6.3.2. Japan
      • 7.6.3.3. India
      • 7.6.3.4. South Korea
      • 7.6.3.5. Taiwan
      • 7.6.3.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Eppendorf AG
  • 9.2. Beckman Coulter, Inc.
  • 9.3. Agilent Technologies, Inc.
  • 9.4. Thermo Fisher Scientific Inc.
  • 9.5. Waters Corporation
  • 9.6. F. Hoffmann-La Roche Ltd
  • 9.7. Shimadzu Corporation
  • 9.8. Bio-Rad Laboratories, Inc.
  • 9.9. PerkinElmer Inc.

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations